Clinical Trials | Medications
Clinical Trials / Medications
- 24 hours
- 0
- 7 days
- –
- 30 days
- +21
- Reactions
- 0
- Reposts
- –
- Comments
- –
Subscriber growth
Clinical Trials | Medications has 1,025 subscribers. It gained 21 subscribers in the last 30 days (2.1%). A typical post is seen by about 19 people within a day, an engagement rate of 1.9%.
Daily numbers, last 30 days
| Date | Subscribers | Change | Posts | Avg. post views |
|---|---|---|---|---|
| 12 Nov | 1,025 | 0 | 3 | 11 |
| 11 Nov | 1,025 | +1 | 7 | 15 |
| 10 Nov | 1,024 | +1 | 5 | 23 |
| 9 Nov | 1,023 | +1 | 5 | 28 |
| 6 Nov | 1,022 | +18 | 4 | 31 |
| 7 Oct | 1,004 | – | 0 | – |
Views as a post ages
Average views at each age, posts of the last 30 days.
- 1 h
- 8
- 3 h
- 8
- 6 h
- 8
- 12 h
- 13
- 24 h
- 19
- 48 h
- 25
- 3 days
- 28
- 7 days
- 29
When it posts
Times in UTC. 40 posts in 90 days.
Recent posts
-
Blood thinner could offer a new way to treat osteoarthritis Osteoarthritis is the most common form of joint disease, a condition that causes joints to become painful and stiff. It can happen to any joint when the cartilage cushioning the ends of bones breaks down or wears away. Currently, there are no approved drugs to slow or stop the underlying disease. But there is a promising development from an unexpected quarter—a blood thinner. https://medicalxpress.com/news/2026-11-blood-thinner-osteoarthritis.html
8 views -
Five lifespan-extending treatments boost the same antioxidant in mice Aging is about far more than wrinkles and gray hair, despite what social media and advertisements might have us believe. The real concern lies beneath the surface, where the biology of aging is intertwined with a host of diseases, from heart disease to neurodegenerative diseases like Alzheimer's and Parkinson's to metabolic disorders and cancer. Targeting the processes that make the body age could have effects far beyond any single disease, potentially easing the burden of several age-related conditions at once. https://medicalxpress.com/news/2026-11-lifespan-treatments-boost-antioxidant-mice.html
11 views -
Papua New Guinean tree offers new lead in search for motor neuron disease treatments The natural world has long been one of medicine's most valuable resources, with countless therapies originating in plants, fungi or algae. So, when University of Wollongong (UOW) researchers went searching for a new treatment for motor neuron disease (MND), they turned to nature. https://medicalxpress.com/news/2026-11-papua-guinean-tree-motor-neuron.html
16 views -
More than a warning sign: Common cardiovascular biomarker may contribute to disease Heart disease is the leading cause of death in the United States, claiming a life nearly every 34 seconds. A major driver of these fatalities is heart failure, a progressive condition where the heart struggles to pump enough blood throughout the body. https://medicalxpress.com/news/2026-11-common-cardiovascular-biomarker-contribute-disease.html
20 views -
One day in the ICU without care from a pharmacist increases risk of death by 20% Patients in intensive care units who don't receive care from a pharmacist for even one day of their stay are 20% more likely to die, according to new research led by the University of Georgia. The work is published in the journal CHEST. https://medicalxpress.com/news/2026-11-day-icu-pharmacist-death.html
15 views -
Could your genes affect your medications? New study highlights high probability Everyone in a diverse, nearly 100,000-person sample carried at least one genetic variant that affects how their body processes medications, and a quarter of those people had been prescribed a medication that is known to be impacted by the variant they carried, a new University of Pittsburgh–led analysis reveals in Science Translational Medicine. https://medicalxpress.com/news/2026-11-genes-affect-medications-highlights-high.html
16 views -
First atlas tracks proteins that cross the blood-brain barrier Your brain is protected by the blood-brain barrier—a network of cells in the brain's blood vessels that serves as a border between the brain and the rest of your bloodstream. But it's not just a barrier; it's a sophisticated interface that shuttles specific molecules between the blood and the brain to keep your brain healthy. https://medicalxpress.com/news/2026-11-atlas-tracks-proteins-blood-brain.html
11 views -
Receptor map uncovers hidden sites that could guide asthma drug design Researchers at the Center for Genomic Regulation (CRG) have developed a new way of identifying new druggable sites on a family of proteins that could help design treatments with fewer side effects for a very wide range of conditions from heart disease to depression. https://medicalxpress.com/news/2026-11-receptor-uncovers-hidden-sites-asthma.html
14 views -
Molecular brace traps two cancer-driving proteins to suppress prostate cancer growth in preclinical tests Many modern cancer drugs typically target a specific protein or signaling pathway to treat tumors. Now, researchers at the University of Michigan Health Rogel Cancer Center are taking a new approach by throwing a molecular wrench into the machinery driving prostate cancer. In preclinical studies, this new approach demonstrated greater antitumor activity while sparing normal cells. https://medicalxpress.com/news/2026-11-molecular-brace-cancer-proteins-suppress.html
11 views -
Effective obesity treatments reach few eligible teens, study finds Despite the arrival of powerful new anti-obesity medications and growing evidence supporting weight-loss surgery for adolescents, the vast majority of eligible teens are receiving neither treatment, according to a new study from Ann & Robert H. Lurie Children's Hospital of Chicago published in JAMA Pediatrics. https://medicalxpress.com/news/2026-11-effective-obesity-treatments-eligible-teens.html
19 views
-
Fatty acid metabolism may help eliminate damaged and senescent cells Researchers have identified a mechanism involving fatty acid metabolism that may determine whether a damaged cell enters senescence and persists in the body or is eliminated through cell death. Published in the journal Cell, the study could open new avenues for treating age-related diseases. Researchers from the University of Eastern Finland contributed to the international study. https://medicalxpress.com/news/2026-11-fatty-acid-metabolism-senescent-cells.html
39 views -
Stronger cholesterol treatment shrinks more plaque in heart arteries, new clinical trial finds Atherosclerosis is a condition in which cholesterol and fat gradually accumulate inside the walls of medium and large arteries, forming a sticky deposit called plaque. As these deposits grow, they narrow the arteries, restricting the flow of oxygen-rich blood to vital tissues and organs. Over time, this buildup can lead to ischemic heart disease (IHD) or stroke. In a recent randomized clinical trial called FLOWPROMOTE, researchers present a strategy to reverse atherosclerosis partially. https://medicalxpress.com/news/2026-11-stronger-cholesterol-treatment-plaque-heart.html
39 views -
Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials For people with painful knee osteoarthritis (OA) who are overweight or have obesity, everyday activities such as walking, climbing stairs and standing up from a chair can be difficult. In two Northwestern University–led Phase III clinical trials involving more than 1,000 participants combined, those taking the highest dose of retatrutide, a new experimental weight-loss injectable drug, lost about one-quarter of their body weight on average. https://medicalxpress.com/news/2026-11-experimental-weight-loss-drug-eases.html
37 views -
Scientists use AI to develop bird flu vaccine that outperforms current stockpiled shot A University of Cambridge team has had a third success with its AI-guided technique for designing vaccines against highly infectious viruses that threaten animal and human health. Its new broad-spectrum bird flu vaccine gave complete protection against globally circulating, diverse variants of the disease in animal trials. https://medicalxpress.com/news/2026-11-scientists-ai-bird-flu-vaccine.html
36 views -
Heart researchers unpack neutral findings from ZEUS, an anti-inflammatory clinical trial Like cholesterol, inflammation causally contributes to the risk of cardiovascular disease, but findings from the clinical trial ZEUS indicate that the road to targeting inflammation may be less straightforward than once thought. ZEUS, a global phase 3 clinical trial led by Mass General Brigham researcher Paul Ridker, M.D., tested a drug that targets interleukin-6 (IL-6), a downstream inflammatory molecule. IL-6 inhibitors are commonly used to treat autoimmune disorders. However, while the new drug known as ziltivekimab lowered IL-6 levels, it did not reduce cardiovascular event rates compared to placebo...
35 views -
Advanced imaging uncovers genomic Achilles' heel that makes cancer cells vulnerable A small subset of vulnerable DNA sites can make cancer cells highly sensitive to targeted drugs called PARP inhibitors, a new study shows. Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, the work revolved around failures of DNA to copy itself at certain sites in genetic chains, which it must do for cells to divide and multiply as part of healing and growth. Cancerous cells depend on protective mechanisms that have evolved to overcome these failures when they are triggered by cancer drugs. https://medicalxpress.com/news/2026-11-advanced-imaging-uncovers-genomic-achilles.html
35 views -
New study challenges belief that women are more sensitive to the effects of cannabis Men who use cannabis occasionally reacted more strongly to smoked cannabis than women with similar use habits, even though the amount of THC in their blood was about the same, according to a new study from UCLA Health. The findings run counter to earlier research suggesting that women are more sensitive to cannabis. https://medicalxpress.com/news/2026-11-belief-women-sensitive-effects-cannabis.html
34 views -
About half of drinkers on GLP-1s say they imbibed less Nearly half of drinkers who take GLP-1 medications have reported declines in consumption, with the effect higher among those at risk of unhealthy alcohol use, a new Harvard study shows. The work, published in the journal JAMA Psychiatry, explores an unexpected side effect of GLP-1s used to treat diabetes and obesity. https://medicalxpress.com/news/2026-11-drinkers-glp-1s-imbibed.html
34 views -
Experimental mRNA therapy promotes repair after heart attack damage Scientists have developed a treatment that 'reawakens' heart muscle cells so they start to divide and help repair damaged muscle. https://medicalxpress.com/news/2026-11-experimental-mrna-therapy-heart.html
32 views -
Crigler-Najjar syndrome: Gene therapy maintains its efficacy four years after treatment The New England Journal of Medicine has published a study on the long-term efficacy of AAV8-mediated gene therapy (GNT0003) in patients with Crigler-Najjar syndrome, an extremely rare congenital liver disorder affecting approximately 500 people in Europe. It is caused by a deficiency of UGT1A1, an enzyme required for bilirubin metabolism. The accumulation of this substance can lead to irreversible neurological damage and, in the most severe cases, death. https://medicalxpress.com/news/2026-11-crigler-najjar-syndrome-gene-therapy.html
31 views
Questions about Clinical Trials | Medications
How many subscribers does Clinical Trials | Medications have?
Clinical Trials | Medications (@clinical_trials) has 1,025 subscribers as of November 12, 2026.
Is Clinical Trials | Medications growing?
Yes. It gained 21 subscribers in the last 30 days (2.1%).
How many people see a post on Clinical Trials | Medications?
A typical post gets about 19 views within 24 hours, roughly 2% of its subscribers (the ERR).
What is Clinical Trials | Medications about?
It is listed in Health, and posts mostly in English. The channel describes itself as: “Clinical Trials / Medications”
Where does Clinical Trials | Medications rank?
By subscribers it is #393 in Health, #5,682 among international channels, #7,925 among English channels, #8,986 worldwide.
Does Clinical Trials | Medications post ads?
None of its 40 posts in the last 30 days carried an ad label such as #ad or Sponsored. Unlabelled promotions can’t be detected.
Statistics updated 55 minutes ago.